Bolero 2 | Bolero | Machines à boissons instantanées | Bravilor Bonamat - France
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial - The Lancet Oncology